Tissue Microarray Market Competitive Landscape 2024-2033 – Major Players and Strategies

Tissue microarray refers to high-throughput technology that enables thorough analysis of an antigen’s expression across numerous tissues and cells in a single experiment using paraffin blocks or formalin. Tissue microarrays are used to simultaneously assess the protein expression of multiple tissue samples.

Sizing and Forecast
The tissue microarray market size has grown rapidly in recent years. It will grow from $11.17 billion in 2023 to $12.36 billion in 2024 at a compound annual growth rate (CAGR) of 10.7%.  The  growth in the historic period can be attributed to rise of precision medicine, drug discovery and development, efficient analysis, rising prevalence of chronic diseases, biobanking initiatives.

The tissue microarray market size is expected to see rapid growth in the next few years. It will grow to $18.68 billion in 2028 at a compound annual growth rate (CAGR) of 10.9%.  The growth in the forecast period can be attributed to emergence of digital pathology, expanded applications, growing biopharmaceutical industry, regulatory support and standards, ai and machine learning integration. Major trends in the forecast period include advancements in imaging technologies, development of 3d tissue microarrays, high-content screening, standardization initiatives, single-cell analysis integration.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/tissue-microarray-global-market-report

Segmentation & Regional Insights
The tissue microarray market covered in this report is segmented –
1) By Type: Immunohistochemistry, Fluorescent In Situ Hybridization, Frozen Tissue Array, Other Types
2) By Technology: Deoxyribonucleic Acid (DNA) Microarray, Polymerase Chain Reaction (PCR), Next-Generation Sequencing, Northern Blotting, Western Blotting
3) By Application: Oncology, Gene Expression Profiling, Single Nucleotide Polymorphism (SNP) Detection, Double-Stranded B-DNA Microarrays, Comparative Genomic Hybridization, Sequencing Bioinformatics
4) By End-User: Pharmaceutical And Biotechnological Companies, Research Organization, Hospitals

North America was the largest region in the tissue microarray market in 2023. Asia-Pacific is expected to be the fastest-growing region in the tissue microarray market report during the forecast period. The regions covered in the tissue microarray market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East,  Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12236&type=smp

Major Driver Impacting Market Growth
The growing number of cancer cases is expected to propel the growth of the tissue microarray market going forward. Cancer is a category of illnesses that can develop in any organ or tissue in the body when aberrant cells proliferate uncontrollably, cross their usual boundaries, and either spread to other organs or invade neighboring body parts. Tissue arrays are used in oncology to examine the expression of cancer-related biomarkers in various tumor samples. For instance, in January 2023, according to the American Cancer Society Inc., a US-based non-profit organization, it is anticipated that there will be 609,820 cancer deaths and 1,958,310 new cancer cases in the US during 2022. Therefore, the growing number of cancer cases is driving the growth of the tissue microarray market.

Key Industry Players
Major companies operating in the tissue microarray market report are Roche Group, Merck & Co. Inc., Thermo Fisher Scientific Inc., Becton, Dickinson Biosciences, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Qiagen NV, PerkinElmer Inc., Bio-Techne Corporation, Tristar Group, Evotec SE, Precision For Medicine Inc., Molecular Devices LLC, BioIVT LLC, BioChain Institute Inc., Creative Bioarray Co, 3DHISTECH Ltd., Novus Biologicals LLC, OriGene Technologies Inc., PREMIER Biosoft International Inc., iSpecimen Inc., OriGene Technologies Inc., Bio SB Inc., ProteoGenex Inc., Z Biotech LLC

The tissue microarray market report table of contents includes:
1. Executive Summary
2. Market Characteristics
3. Market Trends And Strategies
4. Impact Of COVID-19
5. Market Size And Growth
6. Segmentation
7. Regional And Country Analysis
.
.
.
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Leave a Reply

Your email address will not be published. Required fields are marked *